Home › Funds › Caligan Partners LP › TYRA

Caligan Partners LP position in TYRA

TYRA BIOSCIENCES INC COM · Health Care

Caligan Partners LP reported holding 806,986 shares of TYRA (TYRA BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$25.8M, representing 1.51% of its reported portfolio and ranking #16 among its reported holdings. Caligan Partners LP has disclosed TYRA holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)806.99K sh
Reported value held$25.78M
Portfolio Weight1.51%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's TYRA position evolved

Caligan Partners LP first disclosed a stake in TYRA in Q1 2025 at 25,000 shares (US$232K). The position peaked in Q1 2026 at 1,276,968 shares, worth US$48.9M. Across 6 filings, Caligan Partners LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 806,986 shares valued at US$25.8M — a reduction of -469,982 shares quarter over quarter.. Notable position changes include a 660% increase in Q2 2025 (shares rose 46% over the following quarter), a 267% increase in Q3 2025 (shares rose 88% over the following quarter), a 37% trim in Q2 2026 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 25.00K $232.50K New
Q2 2025 189.95K $1.82M Add
Q3 2025 696.83K $9.75M Add
Q4 2025 944.26K $24.82M Add
Q1 2026 1.28M $48.91M Add
Q2 2026 806.99K $25.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TYRA and 13F data

TYRA (TYRA BIOSCIENCES INC COM) is a Health Care company. 57 other funds we track also report a position in TYRA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$389.6M), Alta Partners Management Company, L.P. (US$122.1M), Nextech Invest Ltd. (US$113.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TYRA

All TYRA fund holders →

FAQ

How long has Caligan Partners LP held TYRA?

Caligan Partners LP has disclosed TYRA holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Caligan Partners LP's current position in TYRA?

As of Q2 2026, Caligan Partners LP holds 806.99K shares of TYRA (TYRA BIOSCIENCES INC COM), valued at $25.78M, representing 1.51% of its reported portfolio and ranking #16.

Has Caligan Partners LP been buying or selling TYRA?

In the latest 13F filing (Q2 2026), Caligan Partners LP reduced its position in TYRA. The position peaked in Q1 2026 at 1.28M shares.

Which other funds hold TYRA?

Other major institutional holders of TYRA include RA CAPITAL MANAGEMENT, L.P., Alta Partners Management Company, L.P., Nextech Invest Ltd., among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.